financetom
Business
financetom
/
Business
/
Here's why four-day working week works best for professionals
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Here's why four-day working week works best for professionals
Feb 22, 2019 6:57 AM

A four-day working week! The sound of it is like music to every working individuals’ ear. But will it ever come true? Or is it just another myth?

A couple of economists, however, argued that the world should embrace four-days working a week concept as it reduces the working hours and helps to be attentive at work and better productivity. In a session at the World Economic Forum at Davos this year, Adam Grant and Rutger Bregman argued and explained the pros of working less in a week, theladders.com reported.

“Professionals and workers end up producing just as much, often with higher quality and creativity, and they are also more loyal to the organisations that are willing to give them the flexibility to care about their lives outside of work,” Grant, a psychologist from the Wharton School in Pennsylvania said.

In the 1920s and 1930s, there were actually major capitalist entrepreneurs who discovered that if you shorten the working week, employees become more productive. Henry Ford, for example, discovered that if he changed the working week from 60 hours to 40 hours, his employees would become more productive, because they were not that tired in their spare time.According to multiple studies conducted all over the world, a shorter working week would make people happier and more productive, the report said, adding that OECD data shows that countries with a culture of long working hours have less productivity and GDP per hour worked.

Studies revealed lower stress levels, higher levels of job satisfaction, and an improved sense of work-life balance among the participants, the report said.

A shorter working week is not considered that radical as policymakers have been trying to figure out how to give the workforce more leisure time. “For decades, all the major economists, philosophers, sociologists, they all believed, up until the 1970s, that we would be working less and less,” economist and historian Rutger Bregman said.

First Published:Feb 22, 2019 3:57 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ocugen Completes Dosing in Trial of Gene Therapy for Macular Degeneration
Ocugen Completes Dosing in Trial of Gene Therapy for Macular Degeneration
Apr 19, 2024
08:19 AM EDT, 04/19/2024 (MT Newswires) -- Ocugen ( OCGN ) said Friday it has completed dosing in the second cohort of its Phase 1/2 ArMaDa clinical trial for OCU410 (AAV-hRORA), a modifier gene therapy to treat age-related macular degeneration. The company said the trial will evaluate the safety of unilateral subretinal administration of OCU410 in participants with geographic atrophy....
Huize Holding, PICC Life Insurance to Launch Critical Illness Insurance Product
Huize Holding, PICC Life Insurance to Launch Critical Illness Insurance Product
Apr 19, 2024
08:25 AM EDT, 04/19/2024 (MT Newswires) -- Huize Holding ( HUIZ ) said Friday it is collaborating with PICC Life Insurance to launch a critical illness insurance product. The company said the i Wu You - Low-Threshold Edition product is expected to offer customized and flexible coverage for 28 severe and three mild illnesses. ...
Procter & Gamble Lifts Fiscal 2024 Earnings Growth Outlook Following Third-Quarter Profit Beat
Procter & Gamble Lifts Fiscal 2024 Earnings Growth Outlook Following Third-Quarter Profit Beat
Apr 19, 2024
08:23 AM EDT, 04/19/2024 (MT Newswires) -- Procter & Gamble ( PG ) on Friday raised its full-year core earnings growth outlook as the consumer-goods company reported better-than-expected fiscal third-quarter earnings. The maker of Crest toothpaste and Pampers diapers now anticipates adjusted earnings to rise by 10% to 11% for fiscal 2024, above its prior guidance for an 8% to...
Alvotech Signs Agreement to Expand Access to Humira Biosimilar Adalimumab-ryvk in US
Alvotech Signs Agreement to Expand Access to Humira Biosimilar Adalimumab-ryvk in US
Apr 19, 2024
08:26 AM EDT, 04/19/2024 (MT Newswires) -- Alvotech ( ALVO ) said Friday that it has signed a long-term agreement with an unidentified partner to expand access to Adalimumab-ryvk, a biosimilar to Abbvie's ( ABBV ) drug Humira, in the US. Alvotech's ( ALVO ) chief executive officer, Robert Wessman, said the new partnership agreement supports the biotech company's financial...
Copyright 2023-2026 - www.financetom.com All Rights Reserved